Literature DB >> 12185267

Hepatitis C virus core protein represses the p21 promoter through inhibition of a TGF-beta pathway.

Mi Nam Lee1, Eun Young Jung1, Hyun Jin Kwun1, Hong Ki Jun1, Dae-Yeul Yu2, Yung Hyun Choi3, Kyung Lib Jang1.   

Abstract

The increased proliferation rate of hepatocytes is one of the major risk factors for the development of hepatocellular carcinoma. In this study, we investigated the mechanism by which hepatitis C virus (HCV) core protein represses transcription of the universal cyclin-dependent kinase inhibitor p21 gene in murine fibroblast NIH 3T3 cells. From the transient reporter assays of p21 promoter, we found that the TGF-beta-responsive element (TbetaRE) located between -83 and -74 of the p21 promoter is responsible for the effect. The TGF-beta-induced p21 promoter activity was specifically decreased by HCV core protein and in the presence of the inhibitory Smad7 the repression effect was almost completely abolished. Furthermore, HCV core protein stimulated the growth rate of NIH 3T3 cells and could overcome growth arrest by TGF-beta but not by butyrate, suggesting that HCV core protein stimulates cell cycle progression by repressing p21 transcription through a TGF-beta pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12185267     DOI: 10.1099/0022-1317-83-9-2145

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

Review 1.  Tumor suppressor and hepatocellular carcinoma.

Authors:  Juliette Martin; Jean-Francois Dufour
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

2.  Specific activation of 2'-5'oligoadenylate synthetase gene promoter by hepatitis C virus-core protein: a potential for developing hepatitis C virus targeting gene therapy.

Authors:  Ying Wang; Shan-Shan Mao; Qiong-Qiong He; Yuan Zi; Ji-Fang Wen; De-Yun Feng
Journal:  World J Gastroenterol       Date:  2009-07-07       Impact factor: 5.742

3.  Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression.

Authors:  Byoung Kwon Yoo; Luni Emdad; Zao-zhong Su; Augusto Villanueva; Derek Y Chiang; Nitai D Mukhopadhyay; Alan Scott Mills; Samuel Waxman; Robert A Fisher; Josep M Llovet; Paul B Fisher; Devanand Sarkar
Journal:  J Clin Invest       Date:  2009-02-16       Impact factor: 14.808

4.  Ginsenoside Rg3 restores hepatitis C virus-induced aberrant mitochondrial dynamics and inhibits virus propagation.

Authors:  Seong-Jun Kim; Jae Young Jang; Eun-Jung Kim; Eun Kyung Cho; Dae-Gyun Ahn; Chonsaeng Kim; Han Seul Park; Soung Won Jeong; Sae Hwan Lee; Sang Gyune Kim; Young Seok Kim; Hong Soo Kim; Boo Sung Kim; Jihyung Lee; Aleem Siddiqui
Journal:  Hepatology       Date:  2017-08-01       Impact factor: 17.298

Review 5.  Think small: zebrafish as a model system of human pathology.

Authors:  J R Goldsmith; Christian Jobin
Journal:  J Biomed Biotechnol       Date:  2012-06-03

6.  Identification and functional analysis of a novel splice variant of AC3-33 in breast cancer.

Authors:  Lu Yuan; Fen Hu; Yunfeng Zhang; Lijun Meng; Tianyang An; Yajing Chen; Xiujun Zhang
Journal:  Exp Ther Med       Date:  2019-11-18       Impact factor: 2.447

7.  Hepatitis C virus core protein down-regulates p21(Waf1/Cip1) and inhibits curcumin-induced apoptosis through microRNA-345 targeting in human hepatoma cells.

Authors:  Tzu-Yue Shiu; Shih-Ming Huang; Yu-Lueng Shih; Heng-Cheng Chu; Wei-Kuo Chang; Tsai-Yuan Hsieh
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

Review 8.  Viruses as key modulators of the TGF-β pathway; a double-edged sword involved in cancer.

Authors:  Habibollah Mirzaei; Ebrahim Faghihloo
Journal:  Rev Med Virol       Date:  2018-01-18       Impact factor: 6.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.